Mengshu Cao

机构：Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Nanjing Hydraulic Research Institute, Shaanxi Normal University · ORCID：0000-0002-8735-1262

发表论文 98 篇 · 总被引 1560 次 · h-index 23

代表论文

• Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease (2024 · RMD Open · 被引 8)
• The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis (2024 · Respirology · 被引 4)
• Berberine Ameliorates Pulmonary Fibrosis via Downregulating the TGFBR2 ‐Mediated Signaling (2026 · Chemical Biology & Drug Design · 被引 3)
• Piezo1-mediated mechanotransduction regulates diabetic osteoporosis and hyperglycemia via low-intensity pulsed ultrasound (2025 · Bone · 被引 3)
• Integrin/CD44-targeted liposomes remodel the pulmonary microenvironment to alleviate acute exacerbation of pulmonary fibrosis (2025 · Journal of Controlled Release · 被引 2)
• Targeting the RNA acetyltransferase NAT10 attenuates pulmonary fibrosis via the ac4C-mediated regulation of the C/EBPβ-ITGA11 axis (2026 · International Immunopharmacology · 被引 1)